Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.35. Anticipation surrounds Quest ...

DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and ...

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript February 10, 2026 Quest Diagnostics Incorporated ...

Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the ...

Quest Diagnostics (DGX) stock hits a 52-week high as the company beats estimates with its Q4 2025 financials and set its 2026 ...

Quest Diagnostics (DGX) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.23 per share a year ago. These ...

Quest Diagnostics' board has raised the company's quarterly dividend by 7.5%, to 86 cents from 80 cents, and added $1 billion to the diagnostic information services provider's stock-buyback program.

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Shares of Quest Diagnostics rose after the company's full-year outlook and quarterly results topped Wall Street's expectations. The stock was up 4.9% to $200.53 in midday trading on Tuesday. Earlier ...

Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in ...

The Quest Diagnostics patient service center at 1 Randall Square reopened last week following renovations. Quest leaders ...